日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer

新辅助阿贝西利联合来曲唑与化疗治疗HR+/HER2-高增殖性乳腺癌患者的疗效比较

Martín, Miguel; Guerrero-Zotano, Ángel L; Pérez-López, María E; Ruiz-Borrego, Manuel; Martínez Jáñez, Noelia; Chacón, José I; Gil-Gil, Miguel; Andrés, Raquel; Bermejo, Begoña; Sánchez-Rovira, Pedro; Del Barco, Sonia; Ponce, José J; Fernández, Isaura; Martínez de Dueñas, Eduardo; Hinojo-González, Carmen; González, Marta; García-Garre, Elisa; Hernando, Blanca; de la Haba-Rodriguez, Juan; Álvarez, Isabel M; González-Santiago, Santiago; García-Sáenz, José Á; Santaballa, Ana; Casas, Maribel; Bezares, Susana; Caballero, Rosalía; Rojo, Federico; Alba, Emilio

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

更正:BRECOL (GEICAM/2011-04) 研究中高血压作为转移性乳腺癌和结直肠癌一线贝伐单抗治疗的预测因素

Rodríguez-Lescure, Álvaro; Gallego, Javier; Garcia-Alfonso, Pilar; Massuti, Bartomeu; Márquez, Raúl; Calvo, Lourdes; Sánchez-Rovira, Pedro; Antón, Antonio; Chacón, José Ignacio; Ciruelos, Eva; Ponce, Jose Juan; Santaballa, Ana; Valladares-Ayerbes, Manuel; Dueñas, María Rosario; Alonso, Vicente; Aparicio, Jorge; Encinas, Sara; Robles, Luis; Escudero, María José; Caballero, Rosalía; Bezares, Susana; García-Ortiz, María Victoria; Morales-Ruiz, Teresa; de la Haba-Rodriguez, Juan

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial

GEICAM_CIBOMA试验结果显示,FOXC1表达可预测卡培他滨对三阴性乳腺癌患者的疗效

Rojo, Federico; Taylor, Clive R; Barrios, Carlos; Torrecillas, Laura; Ruiz-Borrego, Manuel; Perez-Buira, Sandra; Bines, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose A; Torres, Roberto; de la Haba-Rodriguez, Juan; Ayala, Francisco; Gomez, Henry; Llombart, Antonio; Rodriguez de la Borbolla, Maria; Baena-Cañada, Jose Manuel; Barnadas, Agusti; Calvo, Lourdes; Herranz, Jesus; Rincon, Raul; Caballero, Rosalia; Bermejo, Begoña; Ray, Partha S; Martin, Miguel

NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN)

NeuroPredict:ABCB1基因多态性及其相关临床因素在慢性化疗引起的周围神经病变(CIPN)中的预测价值研究

Vargas-Aliaga, Alicia; De la Haba, María; Contreras, María José; Morales Estevez, Cristina; Porras, Ignacio; Cano, María Teresa; Pulido, Gema; Gómez, María Auxiliadora; Flores-Paco, Pablo; Juan, De La Haba-Rodriguez; Aranda, Enrique

Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

在 BRECOL (GEICAM/2011-04) 研究中,高血压作为贝伐单抗一线治疗转移性乳腺癌和结直肠癌的预测因素

Rodríguez-Lescure, Álvaro; Gallego, Javier; Garcia-Alfonso, Pilar; Massuti, Bartomeu; Márquez, Raúl; Calvo, Lourdes; Sánchez-Rovira, Pedro; Antón, Antonio; Chacón, José Ignacio; Ciruelos, Eva; Ponce, Jose Juan; Santaballa, Ana; Valladares-Ayerbes, Manuel; Dueñas, María Rosario; Alonso, Vicente; Aparicio, Jorge; Encinas, Sara; Robles, Luis; Escudero, María José; Caballero, Rosalía; Bezares, Susana; García-Ortiz, María Victoria; Morales-Ruiz, Teresa; de la Haba-Rodriguez, Juan

Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology

西班牙肿瘤内科工作量、从业人员数量及需求:西班牙肿瘤内科协会的两项全国性研究

Fernandez Montes, Ana; Elez, Elena; de la Haba-Rodriguez, Juan; Paez, David; Mendez-Vidal, Maria Jose; Felip, Enriqueta; Rodriguez-Lescure, Alvaro

Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: The DEBBRAH trial

曲妥珠单抗德鲁替康治疗HER2阳性乳腺癌伴中枢神经系统受累患者:DEBBRAH试验

Pérez-García, José Manuel; Vaz Batista, Marta; Cortez, Patricia; Ruiz-Borrego, Manuel; Cejalvo, Juan Miguel; de la Haba-Rodriguez, Juan; Garrigós, Laia; Racca, Fabricio; Servitja, Sonia; Blanch, Salvador; Gion, María; Nave, Monica; Fernández-Abad, María; Martinez-Bueno, Alejandro; Llombart-Cussac, Antonio; Sampayo-Cordero, Miguel; Malfettone, Andrea; Cortés, Javier; Braga, Sofía

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine

三阴性 PAM50 非基底细胞型乳腺癌亚型可预测患者从延长辅助卡培他滨治疗中获益

Asleh, Karama; Lluch, Ana; Goytain, Angela; Barrios, Carlos; Wang, Xue Q; Torrecillas, Laura; Gao, Dongxia; Ruiz-Borrego, Manuel; Leung, Samuel; Bines, José; Guerrero-Zotano, Ángel; García-Sáenz, Jose Ángel; Cejalvo, Juan Miguel; Herranz, Jesus; Torres, Roberto; Haba-Rodriguez, Juan de la; Ayala, Francisco; Gómez, Henry; Rojo, Federico; Nielsen, Torsten O; Martin, Miguel

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial

TRAR基因分类器预测HER2阳性和ER阳性乳腺癌患者新辅助治疗反应:来自NeoSphere试验的探索性分析

Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; De Cecco, Loris; Tseng, Ling-Ming; Liu, Mei-Ching; Bermejo, Begoña; Semiglazov, Vladimir; Viale, Giulia; de la Haba-Rodriguez, Juan; Oh, Do-Youn; Poirier, Brigitte; Valagussa, Pinuccia; Gianni, Luca; Tagliabue, Elda

SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021)

SEOM-GETTHI 分子平台实用管理临床指南(2021)

de la Haba-Rodriguez, Juan; Lloret, Ferran Ferragut; Salgado, Maria Angeles Vaz; Arce, Martín Oré; Gutiérrez, Ana Cardeña; Jiménez, Jesús García-Donas; Zambrano, Carmen Beato; Alonso, Rosa María Rodríguez; López, Rafael López; Salas, Nuria Rodriguez